Orega Biotech Competitors and Similar CompaniesClear all
Orega Biotech's competitors and similar companies include VCANBIO, Spur Therapeutics, Codiak Biosciences and Right To Care.
 Orega Biotech Orega Biotech is a company that specializes in the discovery and development of monoclonal antibodies for cancer immunotherapy. |  VCANBIO VCANBIO Cell & Gene Engineering (also known as Zhongyuan Union) is a biotech company that offers health management services and products. |  Spur Therapeutics Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies. |  Codiak Biosciences Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics. |  Right To Care Right To Care is a non-profit organization that supports and delivers prevention, care, and treatment for HIV and associated diseases in South Africa. | |
Founding Date | Founding Date 2010 | Founding Date 1993 | Founding Date 2015 | Founding Date 2015 | Founding Date 2001 |
Type | Type Private | Type Public | Type Subsidiary | Type Public | Type Private |
Tags | |||||
Locations | Locations Écully, FR HQ Montpellier, FR Montpellier, FR | Locations Tianjin, CN HQ | Locations Stevenage, GB HQ Boston, US New York, US | Locations Cambridge, US HQ | |
Employees | Employees 717% increase | Employees 2,0149% decrease | Employees 122 | Employees 992% decrease | Employees 1,817 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.4 b | Valuation ($) N/A | Valuation ($) 2.8 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥1.4b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $22.9m (FY, 2021) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods ¥438.8m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit ¥993.4m (FY, 2025) | Gross profit $8.9m (FY, 2022) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income ¥103.5m (FY, 2025) | Net income ($89m) (FY, 2022) | Net income ($37.2m) (FY, 2021) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 3.7m | Total funding raised N/A | Total funding raised $ 289.3m | Total funding raised $ 168.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
VCANBIO
HQ
Tianjin, CN
Employees
2,014↓ 9% decrease
VCANBIO Cell & Gene Engineering (also known as Zhongyuan Union) is a biotech company that offers health management services and products.
View companySpur Therapeutics
HQ
Stevenage, GB
Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies.
View companyCodiak Biosciences
HQ
Cambridge, US
Employees
99↓ 2% decrease
Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
View companyRight To Care
HQ
Centurion, ZA
Employees
1,817
Right To Care is a non-profit organization that supports and delivers prevention, care, and treatment for HIV and associated diseases in South Africa.
View company